| Gene symbol | RAF1 | Synonyms | CMD1NN, CRAF, NS5, Raf-1, c-Raf | Type of gene | protein-coding |
| Chromosome | 3 | Map location | 3p25.2 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | Raf-1 proto-oncogene, serine/threonine kinase | ||||
| GTO ID | GTC1152 |
| Trial ID | NCT00003236 |
| Disease | Breast Cancer |
| Altered gene | C-Raf |
| Therapeutic/Target gene | Target gene |
| Therapy | ASO |
| Treatment | ISIS 5132|CGP 69846A |
| Phase | Phase2 |
| Recruitment status | Completed |
| Title | Randomized Phase II Study of Human C-raf Kinase Antisense Oligonucleotide Isis 5132 (CGP 69846A) or Human Pkc-Alpha Antisence Oligonucleotide ISIS 3521 (CGP 64128A) in Women With Previously Treated Matastatic Breast Cancer |
| Year | 1999 |
| Country | United States |
| Company sponsor | Eastern Cooperative Oncology Group |
| Other ID(s) | CDR0000066108|ECOG-3197 |
| Vector information | |||
|
|||
| Cohort 1 | |||||
|
|||||